Inventor · disambiguated record
Steven J. Adelman
Also filed as: ADELMAN STEVEN · ADELMAN STEVEN J · ADELMAN STEVEN JAY
13 granted patents·7 pending applications·205 citations·filing 1993–2021
91Inventor score
Top patents by PatentIndex Score
20 records- 0193US6670355B2Method of treating cardiovascular diseaseWYETH CORP·Filed 2002·Granted Dec 30, 2003·99 cites·12 claims
- 0278US5395831ATreating cardiac disorders with Δ9(11)-dehydro-8-isoestroneAMERICAN HOME PROD·Filed 1994·Granted Mar 7, 1995·33 cites·2 claims
- 0365US5552395AΔ9(11)-dehydro-8-isoestrone used to treat alzheimer's diseaseAMERICAN HOME PROD·Filed 1995·Granted Sep 3, 1996·19 cites·1 claims
- 0458US5482935AAnti-atherosclerotic use of 17 alpha-dihydroequilinAMERICAN HOME PROD·Filed 1993·Granted Jan 9, 1996·21 cites·9 claims
- 0556US5510342AMethod of lowering cholesterolAMERICAN HOME PROD·Filed 1995·Granted Apr 23, 1996·19 cites·8 claims
- 0656US2004097538A1Method of treating cardiovascular diseaseWYETH CORP·Filed 2003·Application pending·0 cites
- 0755US12344619B2Drug delivery and imaging chemical conjugate, formulations and methods of use thereofNanophagix LLC·Filed 2021·Granted Jul 1, 2025·0 cites·6 claims
- 0850US11034701B2Drug delivery and imaging chemical conjugate, formulations and methods of use thereofNanophagix LLC·Filed 2016·Granted Jun 15, 2021·0 cites·10 claims
- 0949US5994337AEffects of 17α-dihydroequilenin on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammalsUNIV WAKE FOREST·Filed 1998·Granted Nov 30, 1999·11 cites·4 claims
- 1043US2003176455A1Method of inhibiting cell deathWYETH CORP·Filed 2003·Application pending·0 cites
- 1142US2004167112A1Use of estrogen receptor alpha modulators for the treatment of multiple sclerosisWYETH CORP·Filed 2004·Application pending·0 cites
- 1242US2014322735A1Method to Measure Endogenous Enzymatic Serum/Plasma Cholesterol Esterification by LCAT (Lecithin:Cholesterol Acyltransferase) AssayVASCULARSTRATEGIES LLC·Filed 2014·Application pending·0 cites
- 1339US6271221B1Use of equilenin as an antioxidantAMERICAN HOME PROD·Filed 2000·Granted Aug 7, 2001·0 cites·3 claims
- 1438US2002022617A1Methods for increasing nitric oxide synthase activityAMERICAN HOME PROD·Filed 2001·Application pending·0 cites
- 1537US5496814AMethod of modifying bone resorption with Δ9(11)-dehydro-8-isoestroneAMERICAN HOME PROD·Filed 1994·Granted Mar 5, 1996·2 cites·1 claims
- 1637US2002013335A1Method of treating cardiovascular diseaseAMERICAN HOME PROD·Filed 2001·Application pending·0 cites
- 1733US2013231461A1Method for the isolation of high density lipoproteinVASCULARSTRATEGIES LLC·Filed 2013·Application pending·0 cites
- 1828US6207659B1Effects of 17 α-dihydroequilenin on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammalsUNIV WAKE FOREST·Filed 1999·Granted Mar 27, 2001·0 cites·9 claims
- 1928US6147069AEffects of 17α-dihydroequilenin on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammalsUNIV WAKE FOREST·Filed 1999·Granted Nov 14, 2000·0 cites·8 claims
- 2026US7022688B1Use of 17β-dihydroequilenin as an antioxidantWYETH CORP·Filed 1997·Granted Apr 4, 2006·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Steven J. Adelman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →